Our Blog

Clear All Filters

April 27, 2021

Blog Post 2020 Election/TransitionCriminal JusticeDepartment of Justice

Questions for Joe Biden and Merrick Garland’s Department of Justice

Amid a transition season of bruising battles between progressives and the old guard over Biden’s Cabinet picks, Merrick Garland for Attorney General was one choice that sparked relatively little controversy. Three months into Biden’s presidency, however, Garland is quickly shaping up to be the most consequentially bad Cabinet pick. On any number of important metrics — sweeping out holdovers from the Trump administration and reversing its positions, preventing corporate capture, and acting aggressively to advance the public interest — Garland is failing.

April 27, 2021

Timi Iwayemi

Blog Post Financial RegulationFintech

The Longer Trump’s Acting Comptroller Stays, The More Damage He’ll Do

Under Otting and Brooks’ leadership, the OCC rolled out rules contrary to its responsibility to maintain a federal banking system that is safe against systemic risks and provides aid to all customers. Now they’re all out of power — but Acting Comptroller, Blake Paulson, whose ascent was ensured by Brooks and Mnuchin, has demonstrated no desire to change course from the path set by Trump’s lackeys. That is why Biden needs to act quickly and appoint a Comptroller who recognizes the dangerous precedent set by the Trump administration.

April 22, 2021

Nika Hajikhodaverdikhan

Blog Post Criminal JusticeDepartment of Justice

Merrick Garland: A Potential Wolf in Sheep’s Clothing for Criminal Justice Advocates

Last May, as the country first erupted into protests over George Floyd’s murder at the hands of Minneapolis police officer Derek Chauvin, Biden promised that he would deliver “real police reform” if elected president. The country’s eyes are on Minnesota again this week after a police officer in a Minneapolis suburb shot and killed Daunte Wright, sparking a new wave of protests. This time, Biden need no longer speak in hypotheticals; he is President. Will his administration deliver?

April 22, 2021

Elias Alsbergas

Blog Post Ethics in GovernmentExecutive BranchFinancial RegulationTreasury Department

Delaware Connections Run Deep As DuPont Family's Darla Pomeroy Heads To Treasury

Darla Pomeroy, who is married to an heir to the DuPont family fortune, was just named Senior Advisor to the Office of Domestic Finance at the US Treasury. While her record does not show any familiarity with financial regulatory policy, it reveals instead a history of a powerful corporation highly influential in Delaware placing a close ally in the administration.

April 22, 2021

Press Release Executive BranchFinancial RegulationRevolving Door

Wall Street Lawyer Leading Wall Street Oversight Unsettles Allies Of Gensler

“Oh has chosen to spend over 20 years reinforcing a corrupt status quo in corporate America, in which the largest companies systematically evade democratic accountability. No one so comfortable with the breakdown in the rule of law over corporate America should be entrusted with responsibility for implementing long-overdue accountability on Wall Street.”

April 19, 2021 | The Daily Beast

Miranda Litwak

Op-Ed 2020 Election/TransitionAnti-MonopolyLarry Summers

Silicon Valley’s Favorite Fixer Aims to Stop the Rising Left

But the old guard continues to wield significant power and will be hard pressed to admit defeat, as exemplified by political strategist Bradley Tusk’s continued success. Some might recall Tusk as New York Mayor Bill De Blasio’s biggest critic. Others know him best as Silicon Valley’s favorite political fixer. Teachers’ unions probably remember him comparing them to the NRA. Tusk’s particular brand of politics—lobbying against regulation on behalf of companies he then invests in—in some ways represents the last gasp of corporate control over government that has run rampant since the Reagan era.

April 16, 2021

Fatou Ndiaye Zena Wolf

Blog Post CoronavirusExecutive BranchIntellectual PropertyRevolving Door

The Brother Of A Pharma Lobbyist Advises Biden As He Weighs Vaccine IP Waiver

Despite pushback from progressives, Ricchetti has continued to hold a powerful advisory position in the Biden White House. His background in corporate lobbying and strong ties to the pharmaceutical industry are deeply troubling signs as the Biden Administration faces enormously consequential decisions about how to end the COVID-19 pandemic.

April 15, 2021

Timi Iwayemi

Blog Post Foreign PolicyIntellectual Property

Why Is Politico's Ryan Heath Carrying Water For Big Pharma Monopolies?

The world is currently at an inflection point – Western leaders can choose to continue blocking the TRIPS waiver and lock in a cycle of dependence or empower poorer countries to develop generic vaccines and build infrastructure that will safely put the pandemic behind us. Critiques of the TRIPS waiver claim that most poor countries lack the infrastructure to carry out vaccine operations – a paternalistic view that suggests that manufacturing capacity, supply chain management, and logistics are static in nature. The sooner we act, the more time poorer countries have to begin mobilizing resources needed to make generic vaccine development possible.